Capital Research Global Investors Boston Scientific Corp Transaction History

Capital Research Global Investors

$443 Billion
Q2 2024

A detailed history of Capital Research Global Investors transactions in Boston Scientific Corp stock. As of the latest transaction made, Capital Research Global Investors holds 3,291,200 shares of BSX stock, worth $274 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,291,200

Previous 2,670,426 23.25%

Holding current value

$274 Million

Previous $183 Million 38.58%

% of portfolio

0.06%

Previous 0.04%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$67.33 - $77.71 $41.8 Million - $48.2 Million	620,774 Added 23.25%	3,291,200 $253 Million
Q1 2024 May 14, 2024	BUY	$57.6 - $68.62 $154 Million - $183 Million	2,670,426 New	2,670,426 $183 Million
Q2 2022 Aug 15, 2022	BUY	$35.24 - $47.1 $40.8 Million - $54.5 Million	1,157,193 New	1,157,193 $43.1 Million
Q4 2020 Feb 12, 2021	SELL	$33.15 - $41.97 $50.1 Million - $63.4 Million	-1,511,525 Closed	0 $0
Q3 2020 Nov 13, 2020	SELL	$34.44 - $42.23 $39.8 Million - $48.8 Million	-1,155,238 Reduced 43.32%	1,511,525 $57.8 Million
Q2 2020 Aug 14, 2020	BUY	$30.19 - $39.11 $165,924 - $214,948	5,496 Added 0.21%	2,666,763 $93.6 Million
Q1 2020 May 15, 2020	SELL	$25.83 - $45.71 $46.6 Million - $82.5 Million	-1,804,670 Reduced 40.41%	2,661,267 $86.8 Million
Q4 2019 Feb 18, 2020	BUY	$37.87 - $45.37 $271,527 - $325,302	7,170 Added 0.16%	4,465,937 $202 Million
Q3 2019 Nov 14, 2019	SELL	$40.31 - $43.45 $7,820 - $8,429	-194 Reduced -0.0%	4,458,767 $181 Million
Q2 2019 Aug 14, 2019	SELL	$34.91 - $42.98 $67 Million - $82.4 Million	-1,917,874 Reduced 30.08%	4,458,961 $192 Million
Q1 2019 May 15, 2019	SELL	$32.91 - $40.75 $330 Million - $408 Million	-10,015,149 Reduced 61.1%	6,376,835 $245 Million
Q4 2018 Feb 14, 2019	SELL	$31.73 - $39.04 $95.3 Million - $117 Million	-3,002,544 Reduced 15.48%	16,391,984 $579 Million
Q3 2018 Nov 14, 2018	BUY	$32.83 - $38.63 $289 Million - $341 Million	8,814,601 Added 83.31%	19,394,528 $747 Million
Q2 2018 Aug 14, 2018	BUY	$26.84 - $34.32 $22,840 - $29,206	851 Added 0.01%	10,579,927 $346 Million
Q1 2018 May 15, 2018	BUY	$25.2 - $28.54 $13,280 - $15,040	527 Added 0.0%	10,579,076 $289 Million
Q4 2017 Feb 14, 2018	BUY	$24.79 - $29.8 $28,235 - $33,942	1,139 Added 0.01%	10,578,549 $262 Million
Q3 2017 Nov 14, 2017	BUY	$26.26 - $29.17 $278 Million - $309 Million	10,577,410	10,577,410 $309 Million

Others Institutions Holding BSX

# of Institutions

1,448

Shares Held

1.21B

Call Options Held

8.14M

Put Options Held

8.3M

View Full List

About BOSTON SCIENTIFIC CORP

Ticker BSX
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,431,609,984
Market Cap $119B
Description
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...

More about BSX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital Research Global Investors with notifications on news.

Account

Capital Research Global Investors Boston Scientific Corp Transaction History